PDF(Pubmed)
Abstract：
UNASSIGNED: In recent decades, there has been an interest in clinical pharmacy practice in Türkiye with emerging studies in this area. Despite the recent emergence of diverse pharmacy practice studies in Türkiye, a comprehensive assessment of overall typology of studies and impact has not been conducted thus far.
UNASSIGNED: This systematic review aims to document and assess pharmaceutical policy and practice literature published within the last 5 years in Türkiye. The other aim is to summarise the expected impact of published studies on policy and practice research.
UNASSIGNED: The systematic review was conducted according to the guidelines described in the PRISMA Statement. A comprehensive search approach, incorporating Medical Subject Headings (MeSH) queries and free-text terms was employed to locate pertinent literature related to pharmacy practice and policy in Türkiye. The search covered the period from January 1, 2019, to January 1, 2024, and involved electronic databases including PubMed, Medline Ovid, Scopus, ScienceDirect, Springer Link, PlosOne, and BMC.
UNASSIGNED: In the final grouping, 73 articles met the inclusion criteria and were selected for this review. Among the quantitative studies, majority studies were cross-sectional survey studies. Through the rigorous thematic content analysis seven research domains were developed from the selected literature: drug utilisation and rational drug use, the emerging role of pharmacist, access to medicines and generic medicines, community pharmacy practice, pharmacovigilance/adverse drug reactions, and pharmacoeconomic studies.
UNASSIGNED: The pharmacist role is evolving; however, several challenges remain in fully realising the potential of pharmacists. These include regulatory barriers, limited public awareness of pharmacists\' expanded roles, workforce capacity issues, and the need for ongoing professional development and training. Research studies are needed in the areas of generic prescribing, medicine adherence, intervention studies in community and hospital pharmacy practice, and on pharmacoeconomics and pharmacovigilance.
UNASSIGNED: This systematic review aims to document and assess pharmaceutical policy and practice literature published within the last 5 years in Türkiye. The other aim is to summarise the expected impact of published studies on policy and practice research.
UNASSIGNED: The systematic review was conducted according to the guidelines described in the PRISMA Statement. A comprehensive search approach, incorporating Medical Subject Headings (MeSH) queries and free-text terms was employed to locate pertinent literature related to pharmacy practice and policy in Türkiye. The search covered the period from January 1, 2019, to January 1, 2024, and involved electronic databases including PubMed, Medline Ovid, Scopus, ScienceDirect, Springer Link, PlosOne, and BMC.
UNASSIGNED: In the final grouping, 73 articles met the inclusion criteria and were selected for this review. Among the quantitative studies, majority studies were cross-sectional survey studies. Through the rigorous thematic content analysis seven research domains were developed from the selected literature: drug utilisation and rational drug use, the emerging role of pharmacist, access to medicines and generic medicines, community pharmacy practice, pharmacovigilance/adverse drug reactions, and pharmacoeconomic studies.
UNASSIGNED: The pharmacist role is evolving; however, several challenges remain in fully realising the potential of pharmacists. These include regulatory barriers, limited public awareness of pharmacists\' expanded roles, workforce capacity issues, and the need for ongoing professional development and training. Research studies are needed in the areas of generic prescribing, medicine adherence, intervention studies in community and hospital pharmacy practice, and on pharmacoeconomics and pharmacovigilance.
摘要：
■近几十年来，随着该领域的新兴研究，人们对Türkiye的临床药学实践产生了兴趣。尽管最近在蒂尔基耶出现了各种药学实践研究，迄今为止，尚未对研究的总体类型和影响进行全面评估。
■本系统综述旨在记录和评估过去5年在Türkiye发表的药物政策和实践文献。另一个目的是总结已发表的研究对政策和实践研究的预期影响。
■系统审查是根据PRISMA声明中描述的指南进行的。全面的搜索方法，采用医学主题词（MeSH）查询和自由文本术语来查找与Türkiye的药学实践和政策相关的相关文献。搜索范围为2019年1月1日至2024年1月1日，涉及包括PubMed在内的电子数据库，MedlineOvid,Scopus,ScienceDirect,SpringerLink,PlosOne,BMC。
■在最后的分组中，73篇文章符合纳入标准，入选本综述。在定量研究中，大多数研究是横断面调查研究.通过严格的主题内容分析，从选定的文献中开发了七个研究领域：药物利用和合理用药，药剂师的新角色，获得药品和仿制药，社区药学实践，药物警戒/药物不良反应，和药物经济学研究。
■药剂师的角色正在演变；然而，充分发挥药剂师的潜力仍然存在一些挑战。这些包括监管障碍，公众对药剂师扩大角色的认识有限，劳动力能力问题，以及需要持续的专业发展和培训。在仿制药领域需要进行研究，药物依从性，社区和医院药学实践中的干预研究，以及药物经济学和药物警戒。
■本系统综述旨在记录和评估过去5年在Türkiye发表的药物政策和实践文献。另一个目的是总结已发表的研究对政策和实践研究的预期影响。
■系统审查是根据PRISMA声明中描述的指南进行的。全面的搜索方法，采用医学主题词（MeSH）查询和自由文本术语来查找与Türkiye的药学实践和政策相关的相关文献。搜索范围为2019年1月1日至2024年1月1日，涉及包括PubMed在内的电子数据库，MedlineOvid,Scopus,ScienceDirect,SpringerLink,PlosOne,BMC。
■在最后的分组中，73篇文章符合纳入标准，入选本综述。在定量研究中，大多数研究是横断面调查研究.通过严格的主题内容分析，从选定的文献中开发了七个研究领域：药物利用和合理用药，药剂师的新角色，获得药品和仿制药，社区药学实践，药物警戒/药物不良反应，和药物经济学研究。
■药剂师的角色正在演变；然而，充分发挥药剂师的潜力仍然存在一些挑战。这些包括监管障碍，公众对药剂师扩大角色的认识有限，劳动力能力问题，以及需要持续的专业发展和培训。在仿制药领域需要进行研究，药物依从性，社区和医院药学实践中的干预研究，以及药物经济学和药物警戒。
